11 Radiation Therapy Oncology Group Clinical Trials Administration Sharon Hartson Stine, Director Group Administrator.

Slides:



Advertisements
Similar presentations
Commission on Cancer Mission
Advertisements

American Cancer Society Patient Resource Navigation Program Brandon Costantino University of Maryland Medical Center.
Minorities and the medically underserved in clinical trials Edward L. Trimble, MD, MPH CTEP, DCTD, NCI.
1 LeTourneau University Tim Ochran, MS, DABR, Associate Professor of Radiation Oncology, UTHSCT January 26, 2011.
PLENARY SESSION Fall Group Meeting Miami, FL November 13, 2010.
Guideline for Monitoring of Clinical Trials for Cooperative Groups, CCOP Research Bases, and the Clinical Trials Support Unit (CTSU) Lore Lagrone Program.
ACRIN Presentation Cancer Trials Support Unit Basics September 21, 2011 Martha Hering, RN, CCRP 21 Sept ACRIN Presentation.
Research Protocol ACRIN 6678 Learning About PET/CT Scans: Can PET/CT scans provide helpful information for the treatment of non-small cell lung cancer?
YALE MASTER SLIDE HERE Clinical Research Management – Is not just a handshake deal? Jamie Caldwell, MBA Director Office of Research Services for the Health.
Cancer Disparities Research Partnership Program Process & Outcome Evaluation Amanda Greene, PhD, MPH, RN Paul Young, MBA, MPH Natalie Stultz, MS NOVA Research.
Todays Clinical Trials. Tomorrow’s Cures. Robert L. Comis, MD 1 National Coalition for Cancer Research “Cancer 101” Congressional Briefing 09/10/14.
Are You Ready to Assess For Distress? Lee Tremback, MA, LCSW, OSW-C Oncology Social Worker Eastern Connecticut Cancer Institute John A. DeQuattro Cancer.
International Clinical Trials Dr. Luis A. Salicrup Senior International Cancer Research Specialist Center for Global Health National Cancer Institute National.
A New Point of View: An “Outsider’s” Perspective From the Inside of the NCI and the CCOP Strategic Plan Marge Good, RN, BSN, MPH, OCN MD Anderson Cancer.
Promoting Objectivity in Research by Managing, Reducing, or Eliminating Conflicts of Interest UT HOP UT HOP The University of Texas at Austin.
CALGB Informational Session June 22, 2007 David Hurd, MD Interim Chair Data Audit Committee.
NCI Clinical Trials Reporting Program CTRP User Meeting May 2, 2012 Gene Kraus CTRP Program Director.
ACRIN Research Associates Educational Session Radiation Therapy Oncology Group Research Associates Committee Joyce Neading, RHIT, CTR Program Director,
Comprehensive Thoracic Oncology Program: COG Update CTOP Research Retreat David Nalepinski Director, Oncology Service Line & Business Operations May 23,
The Community Oncology Conference April 23, 2014 Oncology Payment Reform Tammy Chambers Director of Contracting The Center for Cancer and Blood Disorders.
Caveats We are interpreting the guidelines along with you We may have some limited additional insight due to participation during the course of planning.
Annual Meeting 2011 Clinical Trial Development Clinical Trial Development: OEWG, RA’s Role, and Activating Trials on Deadline Martha Heckel Protocol Associate.
NCI Review of the Clinical Trials Process 6 th Annual National Forum on Biomedical Imaging in Oncology James H. Doroshow M.D. April 7, 2005 Bethesda, Maryland.
1 Targeted Strategies to Improve Physician and Patient Access to Cancer Clinical Research An Overview of Coalition Programs and Services Ruth Lambersky.
CTEP, NCI Adverse Event Reporting Programmatic & Workflow Processes Prepared by: Ann Setser May 24, 2010.
Developing Relationships: Cooperative Group Networking Developing Relationships: Cooperative Group Networking Kandie Dempsey, MS, RN, OCN, CCRP Delaware.
BIOMEDICAL IMAGING PROGRAM NATIONAL CANCER INSTITUTE.
Keeping Up-to-Date with SACSCOC MAC Meeting Fall 2013.
Timeliness of Cancer Registry Reporting Ali Johnson, CTR Vermont Cancer Registry Vermont Explor Annual Data Meeting May 1, 2006.
DCB New Grantee Workshop: Post-Award Administration of Grants Brett Hodgkins Team Leader National Cancer Institute Office of Grants Administration.
Gynecologic Oncology Group Gynecologic Oncology Group (GOG) Sharon Stockman, C-CRC The University of Iowa Hospitals Iowa City, IA Chair, GOG Data Management.
LARGEST & FASTEST GROWING INDUSTRY. HOSPITALS Acute care facility Focus on critical needs of patient Average length of stay 4.8 days Classified by type.
1 National Cancer Institute Clinical Trial Cooperative Groups Perspectives from the National Surgical Adjuvant Breast and Bowel Project Joyce Mull, MPM.
Phase II Trial of Neoadjuvant Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated High Grade Unresectable Malignant Peripheral Nerve Sheath.
SARC: Participation and Protocol / Concept Review Robert Maki, MD PhD Memorial Sloan-Kettering Cancer Center.
Cancer Centers In Clinical Trials Sandrine Marreaud Head of Medical Department.
ICTW Punta del Este, Uruguay Role of the Oncology Research Team.
Slide 1 Community Networks to Reduce Cancer Health Disparities Pre-Application Conference May 26, 2004 Bethesda, MD Kenneth C. Chu, PhD Chief, Disparities.
The KU Wichita Center for Breast Cancer Survivorship Judy Johnston, MS, RD/LD Research Instructor Department of Preventive Medicine and Public Health,
Rebecca Nickleson, MS, CRA Assistant Director Office of Research & Sponsored Programs.
Community Networks to Reduce Cancer Health Disparities Community Networks to Reduce Cancer Health Disparities Harold P. Freeman, MD, Director Center to.
James D. Bearden, III, MD, FACP Principle Investigator Gibbs Cancer Center, Spartanburg, SC Gibbs Cancer Center Our NCCCP Journey 1.
University medical center Introducing the UMC Web Site.
Yadvindera (Bobby) Bains MD Director of Radiation Oncology, Laredo Medical Center Adjunct Associate Professor, Dept of Radiation Oncology, University of.
Enrollment and Monitoring Procedures for NCI Supported Clinical Trials Barry Anderson, MD, PhD Cancer Therapy Evaluation Program National Cancer Institute.
Thank you to our Major Underwriter.
CTRP User Call May 1, 2013 Gene Kraus CTRP Program Director.
Office of Rural Health Policy Programs and Priorities Nisha Patel, MA, CHES Director, Community-Based Division Office of Rural Health Policy Department.
CDRP Program Update UPMC McKeesport Program Steering Committee RTOG Meeting Toronto, Canada June 23 rd, 2006.
The TJU Human Research Protection Program (HRPP): Part I – Which Entities/Offices are Involved ? J. Bruce Smith, MD, CIP.
NCCCP Pilot – Clinical Trials Ann O’Mara, PhD, RN, FAAN Program Director Community Clinical Oncology Program Division of Cancer Prevention June 26, 2007.
NCI Clinical Trials Reporting Program CTRP User Meeting June 6, 2012 Gene Kraus CTRP Program Director.
NCI Clinical Trials Reporting Program CTRP User Meeting May 4, 2011.
Medidata Rave Start-Up Information
Florida Cancer Plan Phil Roland, MD FACS FACOG Florida State Chair A Commission on Cancer.
Welcome to Asian Institute of Medical Sciences
1 MARCH 2012 Regulatory Documents & the CTSU.
DEPARTMENT OF RADIOLOGIC TECHNOLOGY AND MEDICAL IMAGING RAD 2325/RT 325 RADIOGRAPHIC PROCEDURES III Inter Hospital Collaborative Research in the Fall 2012.
Survivorship Essentials for Practice Administrators Christina Bach, MBE, MSW, LCSW, OSW-C Carolyn Vachani, MSN, RN, AOCN.
How to Navigate the NCTN and Participate in Imaging Research
A New Model for Imaging and Radiation Therapy Quality Assurance in the National Clinical Trials Network of the National Cancer Institute  Thomas J. FitzGerald,
Learning About PET/CT Scans:
RECOGNITION OF CLINICAL TRIAL CANCER RESEARCH
[ADD OTHER GRANTS AS NECESSARY]
Administrative Details
NRG Main Members Lead Academic Performance Sites (LAPS) 30
[ADD OTHER GRANTS AS NECESSARY]
Clinical Trial Development: RA’s Role, OEWG, and IRB Submissions Martha Heckel Protocol Associate, ACRIN Dept. of Protocol Development & Regulatory.
Clinical Trial Development: NRG Processes and NCI Requirements
NATIONAL CANCER INSTITUTE
Presentation transcript:

11 Radiation Therapy Oncology Group Clinical Trials Administration Sharon Hartson Stine, Director Group Administrator

22 Historic Perspective 1967RTOG was organized under the auspices of the Committee for Radiation Therapy Studies at NCI 1968NCI awarded a grant to Jefferson Medical College to develop a cooperative group to answer radiation therapy and combined modality question, Dr. Simon Kramer was the PI RTOG was fully constituted and developed studies in several disease sites ACR became the grantee for the RTOG cooperative agreement.

33 RTOG Family Tree Department of Health and Human Services (DHHS)Department of Health and Human Services (DHHS) National Institutes of Health (NIH) National Cancer Institute (NCI) Division of Cancer Treatment and Diagnosis (DCTD) –Cancer Therapy Evaluation Program (CTEP) Division of Cancer Prevention (DCP) –Community Clinical Oncology Program (CCOP)

44 Funding Sources RTOG HQ & Stat Center$ 10.1 M CCOP Research Base$ 3.8 M Biospecimen Resource $ 0.8 M Pennsylvania Dept of Health$ 0.7 M Corporate Support$ 3.4 M Other$ 1.5 M Grants are awarded to the American College of Radiology on behalf of RTOG

55 Clinical Trials Administration Grant & Financial AdministrationGrant & Financial Administration Group Membership ActivitiesGroup Membership Activities –New Applications –Roster Updates –Linking to RTOG in RSS –RTOG Passwords Case ReimbursementCase Reimbursement Semiannual Meeting CoordinationSemiannual Meeting Coordination RTOG Publications ManagementRTOG Publications Management Secondary Analysis & Requests for Study DataSecondary Analysis & Requests for Study Data Requests to Use RTOG Biospecimen Resource MaterialsRequests to Use RTOG Biospecimen Resource Materials

66 RTOG Members Over 300 academic and community-based facilities in the United States, Canada and internationally participate in RTOG clinical trials, including nearly 90% of all NCI- designated comprehensive and clinical cancer centers.

77 RTOG Members 342Member Institutions342Member Institutions 36 Full Members36 Full Members 269 Affiliate Members269 Affiliate Members 35 CCOP Members35 CCOP Members 3 Provisional Members3 Provisional Members

88 Membership Requirements Full Members – 25 case credits per yearFull Members – 25 case credits per year Affiliate Members – 5 case credits per yearAffiliate Members – 5 case credits per year CCOP Members – 10 case credits per year (5 must be CCOP Credits)CCOP Members – 10 case credits per year (5 must be CCOP Credits) Data Quality & Timeliness RequirementsData Quality & Timeliness Requirements –Data Quality (no requests for additional info) – 90% –Data Timeliness: Submitted within 90 Days – 80% –Data Timeliness: Submitted within 180 Days – 85% Patient Eligibility – 90%Patient Eligibility – 90% Satisfactory AuditSatisfactory Audit

99 Evaluation Process Evaluations are done in JanuaryEvaluations are done in January Based on the previous calendar yearBased on the previous calendar year Case Accrual, Data Quality, Data Timeliness, and Audit Results are the key components of the evaluationCase Accrual, Data Quality, Data Timeliness, and Audit Results are the key components of the evaluation

10 Case Reimbursement Current Reimbursement Amounts $2,000 for treatment studies$2,000 for treatment studies $2,000 for cancer prevention & symptom management studies$2,000 for cancer prevention & symptom management studies Additional corporate support for some studiesAdditional corporate support for some studies $50 per Follow-Up Form$50 per Follow-Up Form Biospecimens (tissue, blood, urine, etc.) - Reimbursement depends on type of material, $50 - $300.Biospecimens (tissue, blood, urine, etc.) - Reimbursement depends on type of material, $50 - $300.

11 Case Reimbursement Payments for Case Reimbursement - MonthlyPayments for Case Reimbursement - Monthly Case Payment is based on:Case Payment is based on: –Submission of Key Form(s) –Case Eligibility Payments are made to the institutionPayments are made to the institution Follow-Up Payments – QuarterlyFollow-Up Payments – Quarterly Pathology – Semiannual – moving to monthlyPathology – Semiannual – moving to monthly

12 Reimbursement & Credits List Available on RTOG Web site under the “Members” tabAvailable on RTOG Web site under the “Members” tab

13 New Payment Initiatives Phase III Capitation Increases- additional $3000Phase III Capitation Increases- additional $3000 Phase II Capitation Increases- $5000 for treatment armPhase II Capitation Increases- $5000 for treatment arm New Tissue Reimbursement RatesNew Tissue Reimbursement Rates CTSU Ancillary Payment MechanismsCTSU Ancillary Payment Mechanisms Staged Case PaymentsStaged Case Payments